Search for a networks
APL-A-005-02: Phase I - II clinical and pharmacokinetic study of Aplidin (APL) as a 3-hour intravenous infusion every 2 weeks, in children with refractory or relapsed malignant tumours and leukemia (coordination)
- Type of network : Multinational clinical trials
- Geographic coverage : European
- Funding body(ies) : -
- Sponsor : -
Coordinator of multinational clinical trial
- PHARMA MAR SA
- Pharma Mar S.A.
- PharmaMar S.A.
- Avenida de los Reyes, 1. Polígono Industrial La Mina-Norte
- 28770 COLMENAR VIEJO
- SPAIN
- More information
- Phone : 349 18 46 60 00
- Fax : 349 18 46 60 01
- Website
- Contact secretary :
email
Last update: March 2011
Additional information
Further information on this network
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.